Pfizer, BioNTech Rise After FDA Approves Covid Boosters for Children
- ByInvesting.com-
By Liz MoyerInvesting.com -- Pfizer Inc (NYSE:PFE) shares rose after the Food and Drug Administration approved its Covid-19 booster shot for children aged 5 to 11. Pfizer...